Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant
June-Wha Rhee, Raju Pillai, Tianhui He, Alysia Bosworth, Sitong Chen, Liezl Atencio, Artem Oganesyan, Kelly Peng, Tati Guzman, Kara Lukas, Brianna Sigala, Aleksi Iukuridze, Lanie Lindenfeld, Faizi Jamal, Pradeep Natarajan, Scott Goldsmith, Amrita Krishnan, Michael Rosenzweig, F Lennie Wong, Stephen J Forman, Saro Armenian
There is a paucity of information on the association between clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular disease (CVD) in patients with cancer, including those with multiple myeloma (MM) undergoing hematopoietic cell transplant (HCT), a population at high risk of developing CVD after HCT
문서, 2024